Wells Pharma produces commodity products, like all other players in the 503B industry. A 5 mL syringe of 1mg/mL Neostigmine is exactly the same as that product from another outsourcer, and it is exactly the same as that product made in a hospital pharmacy. There are no clinical advantages to any product made by any …
All of the 503B’s tout their “reliability”, but they all have difficulty supplying all of their customers all of the time. Several of our competitors have put customers on “allocation”, supplying only a fraction of the products that their customers order. They have constant problems with backorders. In some cases, they have “fired” their smaller …
There are many 503B outsourcers in the market. According to the FDA’s website, there are currently 70 registered 503B’s. Many of these have very specific “niches” that they serve, many are CMO’s, and many are private-system outsourcers. In the market that Wells Pharma is designed to serve, – acute care hospitals and surgery centers -, …
As a new company in a mature market (outsourced sterile drug preparations), Wells Pharma recognizes that we can’t just be “good”…we must be GREAT. Our competition has name recognition, GPO agreements, large sales teams, and extensive marketing budgets. However, one of the weaknesses of being big is that customer service can suffer. Customers become “a …
This leadership team understands the 503B market is laden with pitfalls and dangers. Because of that, QUALITY is the most important thing we can offer our customers and patients. So, how does Wells Pharma maintain the highest quality standards? In addition to producing products in a sterile environment and using highly-trained Pharmacy Technicians to perform …
As the Vice President of Sales for Wells Pharma, it is my responsibility to lead a brand-new company into the competitive market of 503B sterile outsourced drugs. We provide Ready-To-Use medications to hospitals and surgery centers, saving them time, reducing their cost, extending the shelf-life of their drugs, and increasing the safety for their patients. …
Does Your Compounding Vendor Follow the 5 C’s for Success? Read More »
As Assistant Vice President for the Acute Care Region, I had the pleasure of representing Wells Pharma at the Texas Society of Health System Pharmacists (TSHP) 2021 earlier this month. The event consisted of a Virtual Reverse Exposition and Virtual Hall which both ran smoothly. In my opinion, the biggest takeaway for me from the …
Tony Schwartz Newly Appointed President of Wells Pharma of Houston Houston, Texas – (Business Wire)- The Board of Directors of Wells Pharma of Houston is pleased to announce the appointment of Tony Schwartz as the organization’s President. Mr. Schwartz brings over twenty years of experience to the position with a wealth of knowledge and an …
